Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.67
-0.04 (-2.34%)
At close: Sep 05, 2025, 3:59 PM
1.67
0.00%
After-hours: Sep 05, 2025, 04:41 PM EDT
-2.34% (1D)
| Bid | 1.66 |
| Market Cap | 124.44M |
| Revenue (ttm) | 26.27K |
| Net Income (ttm) | -41.5M |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -41.75 |
| Forward PE | -3 |
| Analyst | Hold |
| Ask | 1.79 |
| Volume | 208,554 |
| Avg. Volume (20D) | 244,787 |
| Open | 1.70 |
| Previous Close | 1.71 |
| Day's Range | 1.66 - 1.70 |
| 52-Week Range | 1.12 - 4.20 |
| Beta | 0.92 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
-13.14%
Inhibikase Therapeutics shares are trading lower. ...
Unlock content with
Pro Subscription
10 months ago
+3.6%
Inhibikase Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced an $8 price target.
